New Drug Speeds Wound Healing in Older Skin by 43%

A cream that clears out damaged cells from aging skin just helped older mice heal wounds dramatically faster, and it might one day do the same for people recovering from surgery or living with chronic injuries.

Scientists at Boston University tested a drug called ABT-263 on aged mice for just five days. When they created small wounds afterward, the treated mice healed much faster than untreated ones.

By day 24, 80% of mice that received the treatment had fully healed wounds. Only 56% of untreated mice had healed in the same time. That's a 43% improvement in healing success.

The drug works by removing senescent cells, often called "zombie cells." These are damaged cells that pile up in aging skin but refuse to die off completely. Instead, they stick around and release inflammatory signals that interfere with the body's repair work.

When researchers applied ABT-263 directly to the skin, something surprising happened. The treatment briefly increased inflammation, which sounds bad but actually seemed to wake up sluggish healing pathways in older tissue.

Gene activity surged in areas tied to wound repair. The skin ramped up collagen production, grew new blood vessels, and activated other processes needed to close and strengthen damaged tissue.

Why This Inspires

This matters beyond wrinkles and age spots. Aging skin becomes less responsive after injury, which can mean prolonged recovery after surgery, wounds that won't close, and serious complications for older adults.

What makes this approach especially promising is that it's topical. Unlike pills that travel through your whole body and might cause side effects, this cream could target problem areas directly.

The treatment only seemed to work in older mice, not young ones. That suggests it specifically targets tissues where zombie cells have built up over time, making it safer and more focused.

Recent research has pushed this even further. A 2026 study created a wound dressing with ABT-263 for diabetic wounds, one of medicine's toughest healing challenges. It improved healing in diabetic mice without detectable toxicity.

Scientists are careful to note that some senescent cells actually help during normal wound repair. The key is removing the harmful lingering ones without disrupting useful early healing signals.

The research is still early and was done in mice, so more work is needed before we know if it's safe or effective in people. Researchers need to answer questions about proper dosing, timing, and whether benefits translate to human skin and various wound types.

But imagine a future where surgeons could prepare older skin before an operation, or where chronic wounds that plague millions could finally close and heal.